skitahoe
9 minutes ago
Provenge was manually prepared, expensive, and not considered a big improvement on existing prostate therapeutics. DCVax-L is a major improvement on the current SOC for GBM and may be determined to produce major improvements on some of the deadliest of cancers, time will tell. Once EDEN is approve